Dose-Adjustment Considerations No evidence-based dose adjustment exists for BPC-157 in the context of SNRI co-administration because no human dose-response data for BPC-157 exist at all
Considering the fact that the activity of recombinant GPx3 from mammalian cells was similar to that of partially purified human plasma GPx3 18 , the significant drop in activity should be related to the absence of the post-translational modification
(PubMed) Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D
De-Stress IV Achieve natural stress reduction with a blend of effective vitamins, minerals, and amino-acids
while excessively high levels of ROS causing lipid, protein and DNA cell damage are known as oxidative stress (Schieber and Chandel, 2014)